concluded that the decline of AGAP2-AS1 contributes to enhancement of cell apoptosis, as well as suppression of cell proliferation and invasion together with migration in glioma in vitro, which is in line with our findings. This evidence concerns the gene AGAP2 and central nervous system cancer.